# Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1

> **NCT03306823** · — · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 556 (estimated)

## Conditions studied

- Cerebral Aneurysm
- Arteriovenous Malformations

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03306823
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2020-09
- **Final completion:** 2021-08
- **Target enrollment:** 556 (ESTIMATED)
- **Last updated:** 2017-10-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03306823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03306823, "Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03306823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*